{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:11:39Z","timestamp":1791231099088,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:label\/><jats:p>Computerized hospital databases are used for clinical and economic research. In France, the hospital administrative database, Programme de m\u00e9dicalisation des syst\u00e8mes d'information (PMSI), could be an interesting means for identifying cases of abuse and dependence in hospitals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>To assess the capability of PMSI to identify cases of abuse and dependence (medicines or illicit drugs; tobacco and alcohol not included).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cross\u2010sectional study, from October 1 to December 31, 2008, in teaching hospitals of Bordeaux. All hospitalizations with an ICD\u201010 code related to possible abuse or dependence were selected. Cases were validated by a committee composed of three pharmacologists using discharge summaries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 34\u2009816 patients registered in the PMSI during the study period, a total of 227 patients were pre\u2010selected as potential cases; 21 patients, hospitalized for abuse or dependence, or complications of which, were included in the analysis. Mean age was 35\u2009years. Substances implicated were buprenorphine (n\u2009=\u20098), benzodiazepines (n\u2009=\u20097), cannabis (n\u2009=\u20096), cocaine (n\u2009=\u20094), heroin (n\u2009=\u20093), amphetamine, ecstasy, morphine, codeine, and tramadol (n\u2009=\u20091, respectively); there was polydrug use in six cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The PMSI database can be useful to identify certain cases of abuse and dependence. This pilot study has been conducted at a local level; as the PMSI is available in all hospital settings in France, further analysis could be done at the regional and national levels. Such data could be a valuable indicator to analyze trends and assess the medical consequences of substance abuse. Copyright \u00a9 2012 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.3369","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T10:47:15Z","timestamp":1351594035000},"page":"1344-1349","source":"Crossref","is-referenced-by-count":27,"title":["Identification of abuse and dependence cases through a hospital database"],"prefix":"10.1002","volume":"21","author":[{"given":"A","family":"Daveluy","sequence":"first","affiliation":[{"name":"Univ. de Bordeaux, U657  F\u201033000 Bordeaux France"},{"name":"INSERM, U657  F\u201033000 Bordeaux France"},{"name":"CHU de Bordeaux Service de Pharmacologie, Centre d'\u00e9valuation et d'information sur la Pharmacod\u00e9pendance\u2010Addictovigilance  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Miremont\u2010Salam\u00e9","sequence":"additional","affiliation":[{"name":"Univ. de Bordeaux, U657  F\u201033000 Bordeaux France"},{"name":"INSERM, U657  F\u201033000 Bordeaux France"},{"name":"CHU de Bordeaux Service de Pharmacologie, Centre d'\u00e9valuation et d'information sur la Pharmacod\u00e9pendance\u2010Addictovigilance  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kostrzewa","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux Service d'information m\u00e9dicale  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Couret","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux Service de Pharmacologie, Centre d'\u00e9valuation et d'information sur la Pharmacod\u00e9pendance\u2010Addictovigilance  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lacoin","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux Service de Pharmacologie, Centre d'\u00e9valuation et d'information sur la Pharmacod\u00e9pendance\u2010Addictovigilance  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lecomte","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux Service de Pharmacologie, Centre d'\u00e9valuation et d'information sur la Pharmacod\u00e9pendance\u2010Addictovigilance  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Moore","sequence":"additional","affiliation":[{"name":"Univ. de Bordeaux, U657  F\u201033000 Bordeaux France"},{"name":"INSERM, U657  F\u201033000 Bordeaux France"},{"name":"CHU de Bordeaux Service de Pharmacologie, Centre d'\u00e9valuation et d'information sur la Pharmacod\u00e9pendance\u2010Addictovigilance  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Gilleron","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux Service d'information m\u00e9dicale  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Haramburu","sequence":"additional","affiliation":[{"name":"Univ. de Bordeaux, U657  F\u201033000 Bordeaux France"},{"name":"INSERM, U657  F\u201033000 Bordeaux France"},{"name":"CHU de Bordeaux Service de Pharmacologie, Centre d'\u00e9valuation et d'information sur la Pharmacod\u00e9pendance\u2010Addictovigilance  F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"MoiseP.Organization for economic co\u2010operation and development. Using hospital administrative databases for a disease\u2010based approach to studying health care systems Aug2001.http:\/\/www.oecd.org\/dataoecd\/28\/10\/1889879.pdf[31 May 2012]."},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39168.496366.55"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629020-00006"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029608319441"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2044"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2006.02633.x"},{"key":"e_1_2_6_8_1","first-page":"635","article-title":"Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution","volume":"55","author":"Couffignal AL","year":"2000","journal-title":"Therapie"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2010.03897.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3280"},{"key":"e_1_2_6_11_1","first-page":"15","article-title":"The French system of evaluation of dependence: establishment in a legal system","volume":"56","author":"Baumevieille M","year":"2001","journal-title":"Therapie"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2008014"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629050-00003"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/pubs.JAMA\u2010ISSN\u20100098\u20107484\u2010288\u201013\u2010jlt1002"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.05417.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809703100706"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139168540"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2263"},{"key":"e_1_2_6_20_1","unstructured":"Afssaps.Centres d'Evaluation et d'Information sur la Pharmacod\u00e9pendance. OPPIDUM (observatoire des produits Psychotropes illicites ou d\u00e9tourn\u00e9s de leur utilisation m\u00e9dicamenteuse). R\u00e9sultats de l'enqu\u00eate2009.www.ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/6eaa9d57c265a8278ad1fe55e1bd95f6.pdf[31 May 2012]."},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360\u20100443.2001.961014337.x"},{"key":"e_1_2_6_22_1","unstructured":"VerdouxH B\u00e9gaudB.Le bon usage des m\u00e9dicaments psychotropes. Office parlementaire d'\u00e9valuation des politiques de sant\u00e9. Assembl\u00e9e Nationale n\u00b03187 S\u00e9nat n\u00b0422 2006."},{"key":"e_1_2_6_23_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9.Modalit\u00e9s d'arr\u00eat des benzodiaz\u00e9pines et m\u00e9dicaments apparent\u00e9s chez le patient \u00e2g\u00e9. HAS 2007.http:\/\/www.has\u2010sante.fr\/portail\/jcms\/c_601507\/arret\u2010des\u2010bzd\u2010recommandations[31 May 2012]."},{"key":"e_1_2_6_24_1","volume-title":"The 2006 Annual Report of the International Narcotics Control Board","author":"INCB","year":"2007"},{"key":"e_1_2_6_25_1","volume-title":"The 2009 Annual Report of the International Narcotics Control Board","author":"INCB","year":"2010"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.154"},{"key":"e_1_2_6_27_1","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers. United States, 1999\u20102008","volume":"60","author":"Centres for Diseases Control and Prevention (CDC)","year":"2011","journal-title":"MMWR"},{"key":"e_1_2_6_28_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).2010 annual report on the state of the drugs problem in Europe. EMCDDA Lisbon 2010.http:\/\/www.emcdda.europa.eu\/publications\/annual\u2010report\/2010[31 May 2012]."},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331970105200101"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1121189X0000333X"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730030-00007"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00414\u2010008\u20100291\u2010x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.892"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2004100"},{"key":"e_1_2_6_35_1","unstructured":"Centre d'\u00e9pid\u00e9miologie sur les causes m\u00e9dicales de d\u00e9c\u00e8s (C\u00e9piDc). Inserm.http:\/\/www.cepidc.vesinet.inserm.fr\/index.html[31 May 2012]."}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3369","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.3369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T04:25:23Z","timestamp":1700540723000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1002\/pds.3369"],"URL":"https:\/\/doi.org\/10.1002\/pds.3369","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]}}}